0001104659-19-015712.txt : 20190318
0001104659-19-015712.hdr.sgml : 20190318
20190318195359
ACCESSION NUMBER: 0001104659-19-015712
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190315
FILED AS OF DATE: 20190318
DATE AS OF CHANGE: 20190318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhang Jack Y.
CENTRAL INDEX KEY: 0001611157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 19689858
MAIL ADDRESS:
STREET 1: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luo Mary Z.
CENTRAL INDEX KEY: 0001611156
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 19689859
MAIL ADDRESS:
STREET 1: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
a4.xml
4
X0306
4
2019-03-15
0
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001611157
Zhang Jack Y.
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
1
0
CEO & Chief Scientific Officer
0001611156
Luo Mary Z.
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
1
0
COO Chief Scientist & Chairman
Common Stock
2019-03-15
4
M
0
514783
15.84
A
2587100
D
Common Stock
2019-03-15
4
F
0
461097
20.23
D
2126003
D
Common Stock
2019-03-15
4
A
0
98368
0
A
2224371
D
Common Stock
2019-03-15
4
F
0
17205
20.23
D
2207166
D
Common Stock
2019-03-16
4
F
0
27476
20.23
D
2179690
D
Common Stock
2019-03-17
4
F
0
32374
20.23
D
2147316
D
Common Stock
2019-03-15
4
M
0
224737
15.84
A
1591443
I
See footnote
Common Stock
2019-03-15
4
F
0
200853
20.23
D
1390590
I
See footnote
Common Stock
2019-03-15
4
A
0
41522
0
A
1432112
I
See footnote
Common Stock
2019-03-15
4
F
0
7317
20.23
D
1424795
I
See footnote
Common Stock
2019-03-16
4
F
0
11832
20.23
D
1412963
I
See footnote
Common Stock
2019-03-17
4
F
0
13941
20.23
D
1399022
I
See footnote
Common Stock
7327679
I
See footnote
Common Stock
5000
I
See footnote
Common Stock
200000
I
See footnote
Employee Stock Option (right to buy)
15.84
2019-03-15
4
M
0
514783
0
D
2019-03-27
Common Stock
0
0
D
Employee Stock Option (right to buy)
22.25
2019-03-15
4
A
0
262182
0
A
2027-03-15
Common Stock
262182
262182
D
Employee Stock Option (right to buy)
15.84
2019-03-15
4
M
0
224737
0
D
2019-03-27
Common Stock
0
0
I
See footnote
Employee Stock Option (right to buy)
22.25
2019-03-15
4
A
0
110671
0
A
2027-03-15
Common Stock
110671
110671
I
See footnote
The reported shares were withheld to satisfy the reporting person's tax liability in connection with the option exercise.
The reported shares are represented by restricted stock units, or RSUs, which vest in three equal annual installments beginning on March 15, 2020.
The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.
The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust (the "BLZ Trust") are the sole owners.
The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
The shares are held of record by the BLZ Trust. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
Shares subject to the option are fully vested and immediately exercisable.
Shares subject to the option vest in three equal annual installments beginning on March 15, 2020.
/s/ Eva Wen, by power of attorney for Jack Y. Zhang
2019-03-18
/s/ Eva Wen, by power of attorney for Mary Z. Luo
2019-03-18